TY  - GEN
AU  - Trancart,Stéphanie
AU  - Charreau,Isabelle
AU  - Marchou,Bruno
AU  - Bocquentin,Muriel
AU  - Molina,Jean-Michel
AU  - Izopet,Jacques
AU  - Tangre,Philippe
AU  - Aboulker,Jean-Pierre
AU  - Taburet,Anne-Marie
TI  - Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen
SN  - 1098-6596
PY  - 2012///0824
KW  - Adult
KW  - Alkynes
KW  - Amino Acid Substitution
KW  - Anti-HIV Agents
KW  - blood
KW  - Benzoxazines
KW  - Chromatography, High Pressure Liquid
KW  - Cyclopropanes
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Drug Combinations
KW  - Drug Resistance, Viral
KW  - Emtricitabine
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Reverse Transcriptase
KW  - antagonists & inhibitors
KW  - HIV-1
KW  - drug effects
KW  - Half-Life
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Mutation
KW  - Reverse Transcriptase Inhibitors
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1128/AAC.05452-11
ER  -